IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IOBT is expected to report earnings to rise 8.82% to -37 cents per share on August 11
Q2'25
Est.
$-0.37
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.17
Q3'24
Missed
by $0.07
Q2'24
Beat
by $0.03
The last earnings report on May 14 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 10.60M shares outstanding, the current market capitalization sits at 119.24M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOBT showed earnings on May 14, 2025. You can read more about the earnings report here.